Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon (PREVEIL)
A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery
Sponsor: SurModics, Inc.
A NA clinical study on Peripheral Arterial Disease and Peripheral Vascular Diseases, this trial is completed. The trial is conducted by SurModics, Inc. and has accumulated 14 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
-
Apr 2022 — Sep 2022 [monthly]
Completed NA
-
Sep 2021 — Apr 2022 [monthly]
Completed NA
▶ Show 9 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
May 2020 — Nov 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Nov 2018 — May 2020 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Nov 2018 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- SurModics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .